- General population
- Infants (<1 year)
- Children (1-11 years)
- Hospital
- Primary care
- Respiratory syncytial virus
- Pharmacological intervention
- Monoclonal antibodies
- Nirsevimab
Population: General population
Individuals who do not belong to a defined subgroup with specific characteristics, representing the broader population
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- Respiratory syncytial virus
- Bordetella pertussis
- Blood sample
- Nasopharyngeal swab
- General population
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Hospital
- Intensive care unit
- Respiratory syncytial virus
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- General population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Non pharmacological intervention
- Lung ultrasound
- General population
- Infants (<1 year)
- Children (1-11 years)
- Hospital
- Emergency department
- Respiratory syncytial virus
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Respiratory syncytial virus
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Respiratory syncytial virus
- General population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Pharmacological intervention
- Monoclonal antibodies
- Nirsevimab
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- Monkeypox virus
- Blood sample
- PBMC
- Pharmacological intervention
- Vaccination
- MVA-BN
- Dryvax
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Children (1-11 years)
- Adolescents (12-17 years)
- Community
- Monkeypox virus
- Adults (18-64 years)
- General population
- Children (1-11 years)
- Adolescents (12-17 years)
- People at high risk of STIs
- Men who have sex with men
- Primary care
- Monkeypox virus